What question did this study set out to answer?

To analyze clinical features and prognosis of peripheral T-cell lymphomas in a Mexican referral center.

December 8, 2025BloodOpen Access

Peripheral T-cell lymphomas: Real-world insights into clinical features and prognosis

View Full Paper

Ask AI

Bookmark

Authors

RFRodrigo Figueroa-Méndez ACAmairani Carpintero-Díaz

Discussion

Member takes

Overview

Retrospective analysis reveals poor outcomes and high R/R rates in patients with peripheral T-cell lymphomas in Mexico, suggesting need for better therapies.

Key Points

To analyze clinical features and prognosis of peripheral T-cell lymphomas in a Mexican referral center.
Retrospective analysis of patients with PTCL from a national referral center in Mexico (2011-2024)
Descriptive and comparative statistics were performed
Overall survival and progression-free survival were analyzed using Kaplan-Meier curves and log-rank test.
128 patients analyzed with median age of 46 years and male-to-female ratio of 1:1
55.5% had B symptoms; 71.1% diagnosed with advanced disease
Survival outcomes were poor, with median overall survival of 15 months and progression-free survival of 9 months.

Cite This Study

Figueroa-Méndez et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d2d9 https://doi.org/10.1182/blood-2025-5421

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

Peripheral T-cell lymphomas: Real-world insights into clinical features and prognosis

View Full Paper

Ask AI

Bookmark

Authors

RFRodrigo Figueroa-Méndez ACAmairani Carpintero-Díaz

Discussion

Member takes

Overview

Retrospective analysis reveals poor outcomes and high R/R rates in patients with peripheral T-cell lymphomas in Mexico, suggesting need for better therapies.

Key Points

To analyze clinical features and prognosis of peripheral T-cell lymphomas in a Mexican referral center.
Retrospective analysis of patients with PTCL from a national referral center in Mexico (2011-2024)
Descriptive and comparative statistics were performed
Overall survival and progression-free survival were analyzed using Kaplan-Meier curves and log-rank test.
128 patients analyzed with median age of 46 years and male-to-female ratio of 1:1
55.5% had B symptoms; 71.1% diagnosed with advanced disease
Survival outcomes were poor, with median overall survival of 15 months and progression-free survival of 9 months.

Cite This Study

Figueroa-Méndez et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d2d9 https://doi.org/10.1182/blood-2025-5421

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark